ccdd_code,ccdd_formal_name,ccdd_type,policy_type,policy_reference,special_groupings_status,special_groupings_status_effective_time,changes
"02244080","DIMETANE EXPECTORANT DC (brompheniramine maleate 2 mg per 5 mL and guaifenesin 100 mg per 5 mL and hydrocodone bitartrate 1.8 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL syrup) FOUNDATION CONSUMER BRANDS, LLC","MP","500001","http://www.gazette.gc.ca/rp-pr/p1/2017/2017-06-17/html/reg8-eng.php","Active","20170919","ccdd_formal_name: ""DIMETANE EXPECTORANT DC (brompheniramine maleate 2 mg per 5 mL and guaifenesin 100 mg per 5 mL and hydrocodone bitartrate 1.8 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL syrup) GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC"" -> DIMETANE EXPECTORANT DC (brompheniramine maleate 2 mg per 5 mL and guaifenesin 100 mg per 5 mL and hydrocodone bitartrate 1.8 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL syrup) FOUNDATION CONSUMER BRANDS, LLC"
"02244080","DIMETANE EXPECTORANT DC (brompheniramine maleate 2 mg per 5 mL and guaifenesin 100 mg per 5 mL and hydrocodone bitartrate 1.8 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL syrup) FOUNDATION CONSUMER BRANDS, LLC","MP","500002","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919","ccdd_formal_name: ""DIMETANE EXPECTORANT DC (brompheniramine maleate 2 mg per 5 mL and guaifenesin 100 mg per 5 mL and hydrocodone bitartrate 1.8 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL syrup) GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC"" -> DIMETANE EXPECTORANT DC (brompheniramine maleate 2 mg per 5 mL and guaifenesin 100 mg per 5 mL and hydrocodone bitartrate 1.8 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL syrup) FOUNDATION CONSUMER BRANDS, LLC"
"02380897","PMS-NABILONE (nabilone 0.25 mg oral capsule) PHARMASCIENCE INC","MP","500007","http://laws-lois.justice.gc.ca/eng/acts/C-38.8/FullText.html","Active","20170919","ADDED"
